Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry

PURPOSE: As a means of limiting normal tissue toxicity, proton-beam therapy (PBT) is an emerging radiation modality for glioblastoma (GBM) reirradiation. However, data for recurrent GBM treated with PBT reirradiation is limited. Therefore, we analyzed treatment patterns, toxicities, and clinical out...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Ali M., Khairnar, Rahul, Sharma, Ankur M., Larson, Gary L., Tsai, Henry K., Wang, Chiachien J., Halasz, Lia M., Chinnaiyan, Prakash, Vargas, Carlos E., Mishra, Mark V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557126/
https://www.ncbi.nlm.nih.gov/pubmed/33083661
http://dx.doi.org/10.1016/j.adro.2020.03.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557126/
https://www.ncbi.nlm.nih.gov/pubmed/33083661
http://dx.doi.org/10.1016/j.adro.2020.03.022

Ejemplares similares